Bio-Techne (TECH) ebitda was $391M in FY2026 (+54% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2026
$391M
+54%
2025
$253M
-31%
2024
$369M
-18%
2023
$449M
+1%
2022
$446M
+18%
2021
$377M
+37%
2020
$275M
+7%
2019
$257M
+12%
2018
$229M
+17%
2017
$195M
-4%
2016
$203M
+7%
2015
$190M
+4%
2014
$182M
+1172%
2013
$14M
-92%
2012
$179M
+3%
2011
$173M
+4%
2010
$166M
+3%
2009
$160M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$121M
Q1 2026
$102M
Q4 2025
$84M
Q3 2025
$84M
Q2 2025
$24M
Q1 2025
$69M
Q4 2024
$81M
Q3 2024
$78M
Q2 2024
$102M
Q1 2024
$104M
Q4 2023
$90M
Q3 2023
$94M
Source: TECH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.